RxDoctor Payments Data

Darcy Wolsey, MD

Ophthalmology · Murray, UTNPI 1174575153

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (34.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 41.0% of the total. Reporting peaked in 2023 at $4,484 and has fallen 86.2% since, to $619 in 2025. Among ophthalmology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,584in general payments, 2019–2025

Across 81 payments — averaging $130.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$4K
  • Carl Zeiss Meditec, Inc.$3K
  • Alcon$2K
  • Glaukos Corporation$448
  • AbbVie$300
  • Novartis$165
  • plus $206 from 7 others

What the payments were for

  • Consulting fees$3,00028%
  • Speaking & faculty fees$2,90027%
  • Travel & lodging$9849%
  • Food & beverage$3,68135%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,584 in reported general payments places this provider in the 90th percentile of 191 ophthalmology providers in Utah.

See all ophthalmology providers in Utah

Medicare billing

Part B allowed, 2024
$71,264
Medicare patients
226
Services billed
526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate126$3,938
Ketorolac Tromethamine35$1,596
Ofloxacin92$944
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha30$359
Latanoprost36$339
Brimonidine Tartrate14$69

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →